Prevalence, determinants, and outcomes of SARS-COV-2 infection among cancer patients. A population-based study in northern Italy.
Luigino Dal MasoAntonella ZucchettoLuigino Dal MasoStefania Del ZottoFrancesca TabogaElena ClagnanLucia FratinoFrancesca TosoliniIvana BurbaPublished in: Cancer medicine (2021)
Albeit cancer patients reported reduced SARS-CoV-2 infection risk, those infected showed higher mortality than uninfected ones and infected cancer-free population. Study findings claim for continuing to protect cancer patients from SARS-CoV-2, without reducing the level of oncologic care.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- risk factors
- healthcare
- papillary thyroid
- hiv infected
- palliative care
- squamous cell
- quality improvement
- squamous cell carcinoma
- radical prostatectomy
- type diabetes
- prostate cancer
- robot assisted
- pain management
- cardiovascular disease
- young adults
- affordable care act
- health insurance
- antiretroviral therapy
- childhood cancer